The US Food and Drug Administration and industry worked hard to clear their desks in the days leading up to Thanksgiving, issuing a bevy of drug development announcements. Here are just a few of the week's most notable events:
Keeping Track: Oxbryta Approval Headlines Pre-Thanksgiving Week Of News
The latest drug development news and highlights from our US FDA Performance Tracker.
